Tudor Investment Corp’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-35,206
Closed -$952K 3928
2025
Q2
$952K Buy
+35,206
New +$1.02M ﹤0.01% 2171
2025
Q1
Sell
-20,342
Closed -$806K 3713
2024
Q4
$806K Sell
20,342
-20,531
-50% -$777K ﹤0.01% 1884
2024
Q3
$1.39M Buy
40,873
+1,989
+5% +$56K 0.01% 1423
2024
Q2
$843K Buy
+38,884
New +$818K ﹤0.01% 1548
2023
Q3
Sell
-33,950
Closed -$865K 2907
2023
Q2
$865K Sell
33,950
-1,831
-5% -$44.4K 0.01% 1394
2023
Q1
$798K Buy
+35,781
New +$865K 0.01% 1338
2022
Q4
Sell
-30,966
Closed -$514K 2875
2022
Q3
$514K Buy
+30,966
New +$697K 0.01% 1379
2022
Q2
Sell
-24,084
Closed -$664K 2537
2022
Q1
$664K Buy
24,084
+4,447
+23% +$127K 0.02% 1117
2021
Q4
$809K Buy
+19,637
New +$868K 0.01% 1139
2021
Q3
Sell
-19,249
Closed -$770K 2821
2021
Q2
$770K Buy
19,249
+14,339
+292% +$613K 0.01% 971
2021
Q1
$264K Sell
4,910
-20,951
-81% -$1.21M 0.01% 1347
2020
Q4
$1.27M Buy
+25,861
New +$1.2M 0.04% 601

Other funds holding VCYT

Tudor Investment Corp's VCYT Position: Q3 2025 in Review

Tudor Investment Corp sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 35,206 shares — an estimated $952K sold.

Tudor Investment Corp first reported a position in VCYT in Q4 2020 and held it in 12 quarters. The position peaked at $1.39M in Q3 2024. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Tudor Investment Corp reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 35,206 Veracyte shares in Q3 2025, an estimated $952K.
  • Tudor Investment Corp first reported a position in Veracyte in Q4 2020 and held it in 12 quarters.
  • Tudor Investment Corp's Veracyte position peaked at $1.39M in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.